
electroCore shows growth with new sales and FDA plans, targeting strong revenue and profits by 2027
electroCore is improving operationally and financially, driven by expanding its sales force and strong growth in its Quell Fibromyalgia product. The company aims for over 30% revenue growth by fiscal year 2026, gross margins above 85%, and positive a...





